Skip to Main Content

Author Details

Maria C Vladoiu
The Hospital for Sick Children
2014
21
18
Antoine Forget (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36131014Failure of human rhombic lip differentiation underlies medulloblastoma formation.Nature2022
35853870A brain precursor atlas reveals the acquisition of developmental-like states in adult cerebral tumours.Nat Commun2022
35618754Author Correction: scRNA-seq in medulloblastoma shows cellular heterogeneity and lineage expansion support resistance to SHH inhibitor therapy.Nat Commun2022
36446943Author Correction: Failure of human rhombic lip differentiation underlies medulloblastoma formation.Nature2022
36471070K27M in canonical and noncanonical H3 variants occurs in distinct oligodendroglial cell lineages in brain midline gliomas.Nat Genet2022
34045740Author Correction: Locoregional delivery of CAR T cells to the cerebrospinal fluid for treatment of metastatic medulloblastoma and ependymoma.Nat Med2021
33741928The transcriptional landscape of Shh medulloblastoma.Nat Commun2021
32294450Medulloblastoma Arises from the Persistence of a Rare and Transient Sox2<sup>+</sup> Granule Neuron Precursor.Cell Rep2020
32686664An OTX2-PAX3 signaling axis regulates Group 3 medulloblastoma cell fate.Nat Commun2020
32445698Metabolic Regulation of the Epigenome Drives Lethal Infantile Ependymoma.Cell2020
31768071Stalled developmental programs at the root of pediatric brain tumors.Nat Genet2019
31863004scRNA-seq in medulloblastoma shows cellular heterogeneity and lineage expansion support resistance to SHH inhibitor therapy.Nat Commun2019
31664194Recurrent noncoding U1 snRNA mutations drive cryptic splicing in SHH medulloblastoma.Nature2019
29542855Mesoscopic characterization of prostate cancer using Raman spectroscopy: potential for diagnostics and therapeutics.BJU Int2018
28394352Spatial heterogeneity in medulloblastoma.Nat Genet2017
26933916Galectin signatures contribute to the heterogeneity of breast cancer and provide new prognostic information and therapeutic targets.Oncotarget2016
26168167A Mutation in the Carbohydrate Recognition Domain Drives a Phenotypic Switch in the Role of Galectin-7 in Prostate Cancer.PLoS One2015
26543238Design of a peptidic inhibitor that targets the dimer interface of a prototypic galectin.Oncotarget2015
24452506Intracellular galectins in cancer cells: potential new targets for therapy (Review).Int J Oncol2014
25367122Cytosolic galectin-7 impairs p53 functions and induces chemoresistance in breast cancer cells.BMC Cancer2014
25277199Expression and functions of galectin-7 in ovarian cancer.Oncotarget2014
  • 1 - 21 of 21

Recommended Authors

Weill Cornell Medicine and New York Presbyterian Hospital
Career Start Year 2013
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 2011
Number of shared co-authors 1
the University of Texas MD Anderson Cancer Center
Career Start Year 2009
Number of shared co-authors 1
University of Toronto
Career Start Year 2006
Number of shared co-authors 33
Juravinski Cancer Centre
Career Start Year 2006
Number of shared co-authors 0
Institute of Biomedical Science and Children's Hospital, Fudan University
Career Start Year 2006
Number of shared co-authors 0
Cancer Science Institute of Singapore, National University of Singapore
Career Start Year 2005
Number of shared co-authors 1
University of California san francisco
Career Start Year 2005
Number of shared co-authors 0
Stanford University School of Medicine
Career Start Year 2004
Number of shared co-authors 1
University of California los angeles
Career Start Year 2003
Number of shared co-authors 0
Universite Paris Cite, CNRS
Career Start Year 2002
Number of shared co-authors 1
Institute of Anatomy, Technische Universitat Dresden School of Medicine
Career Start Year 2001
Number of shared co-authors 2
University of Virginia
Career Start Year 2000
Number of shared co-authors 1
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 1
Maastricht University Medical Centre+
Career Start Year 1997
Number of shared co-authors 1
All-Island Cancer Research Institute, UCD Conway Institute, University College Dublin
Career Start Year 1996
Number of shared co-authors 0
Odette Cancer Centre, University of Toronto
Career Start Year 1995
Number of shared co-authors 0
Cleveland Clinic.
Career Start Year 1994
Number of shared co-authors 11
Oncode Institute
Career Start Year 1993
Number of shared co-authors 1
Georgetown University
Career Start Year 1993
Number of shared co-authors 0
Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield
Career Start Year 1991
Number of shared co-authors 0
University of Perugia
Career Start Year 1991
Number of shared co-authors 5
Telethon Kids Institute
Career Start Year 1990
Number of shared co-authors 4
Royal Melbourne Hospital, The University of Melbourne
Career Start Year 1989
Number of shared co-authors 1
Instituto do Cancer do Estado de Sao Paulo, Faculdade de Medicina de Sao Paulo
Career Start Year 1989
Number of shared co-authors 0
Candiolo Cancer Institute, Fondazione del Piemonte per l'Oncologia (FPO) - IRCCS
Career Start Year 1988
Number of shared co-authors 5
University of Utah
Career Start Year 1986
Number of shared co-authors 2
Louisiana State University Health Sciences Center
Career Start Year 1983
Number of shared co-authors 0
Queen's University
Career Start Year 1982
Number of shared co-authors 5
Knight Cancer Institute, Oregon Health and Sciences University
Career Start Year 1976
Number of shared co-authors 11

Collaborators

The Hospital for Sick Children
Co-authored papers 14
The Hospital for Sick Children, University of Toronto
Co-authored papers 8
The Research Institute of the McGill University Health Centre, McGill University
Co-authored papers 8
McGill University Health Centre (MUHC), Montreal Children's Hospital (MCH)
Co-authored papers 8
Ontario Institute for Cancer Research, University Avenue
Co-authored papers 8
Institut Curie, PSL Research University
Co-authored papers 8
Hospital for Sick Children
Co-authored papers 8
University of Wollongong
Co-authored papers 7
The Hospital for Sick Children
Co-authored papers 7
The Hospital for Sick Children
Co-authored papers 7
BioBox Analytics Inc.
Co-authored papers 6
Center for Cancer and Blood Disorders, Children's Hospital Colorado.
Co-authored papers 6
Cumming School of Medicine, University of Calgary
Co-authored papers 6
Centre de Recherche du Centre Hospitalier de l'Universite de Montreal (CRCHUM)
Co-authored papers 6
Hospital de Santa Maria, Centro Hospitalar Universitario Lisboa Norte (CHULN)
Co-authored papers 5
University of Naples
Co-authored papers 5
Hospital for Sick Children
Co-authored papers 5
Co-authored papers 5
Dana-Farber Cancer Institute
Co-authored papers 5
Institut Curie, PSL Research University, CNRS UMR, INSERM
Co-authored papers 5
University of British Columbia
Co-authored papers 5
University of Toronto
Co-authored papers 5
The Hospital for Sick Children
Co-authored papers 4
Erasmus MC Cancer Institute, University Medical Center Rotterdam
Co-authored papers 4
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 4
Seoul National University Children's Hospital
Co-authored papers 4
Heersink School of Medicine, University of Alabama at Birmingham
Co-authored papers 4
Kitasato University School of Medicine
Co-authored papers 4
Erasmus MC Cancer Institute
Co-authored papers 4
Clinical Research Division, Fred Hutchinson Cancer Center
Co-authored papers 4